Desire for control and Choice of Antiemetic Treatment for cancer Chemotherapy.

Deals with a study which examined whether allowing cancer chemotherapy patients to choose their antiemetic regimen would reduce both physical and emotional distress and whether the provision of choice affected patients differently depending on their degree of desire for control (DFC). Measures of perceived control which were administered; Levels of DFC; Implications for practitioners; Commentaries on the research.